Emcure Pharmaceuticals Ltd.

BSE: 544210 | NSE: EMCURE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE168P01015 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Emcure Pharmac Emcure Pharmaceuticals Ltd. | BSE 1499.00 40.05 (2.75%) | NSE 1502.80 44.40 (3.04%) | Trade | Add

BSE Live

Mar 17, 11:07

1499.00 40.05 (2.75%)

Volume

AVERAGE VOLUME

5-Day

9,643

10-Day

21,578

30-Day

18,067

5,523

Prev. Close

1458.95
Open Price

1480.00

Bid Price (Qty.)
1500.45 (1)
Offer Price (Qty.)
1502.50 (14)

NSE Live

Mar 17, 11:07

1502.80 44.40 (3.04%)

Volume

AVERAGE VOLUME

5-Day

309,849

10-Day

278,852

30-Day

210,353

123,275

Prev. Close

1458.40
Open Price

1474.50

Bid Price (Qty.)
1501.30 (42)
Offer Price (Qty.)
1502.80 (6)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Emcure Pharmaceuticals (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	2,335.68	2,406.73	2,218.29	2,053.58	2,139.42
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	7.81	40.85	38.73
Revenue From Operations [Net]	2,335.68	2,406.73	2,210.48	2,012.73	2,100.69
Total Operating Revenues	2,375.71	2,453.70	2,241.43	2,057.79	2,137.01
Other Income	137.62	90.88	61.00	37.46	40.42
Total Revenue	2,513.32	2,544.58	2,302.43	2,095.25	2,177.43
EXPENSES
Cost Of Materials Consumed	559.85	533.53	370.95	319.08	391.22
Purchase Of Stock-In Trade	191.61	196.55	177.36	262.68	308.75
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	59.70	14.71	60.34	-49.03	-91.92
Employee Benefit Expenses	545.35	516.14	484.13	465.73	418.99
Finance Costs	137.22	126.65	88.05	100.41	75.73
Depreciation And Amortisation Expenses	154.97	129.84	119.97	115.83	104.43
Other Expenses	595.78	622.36	621.04	558.31	518.47
Total Expenses	2,244.48	2,139.79	1,921.84	1,773.02	1,725.66
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	268.84	404.79	380.58	322.23	451.77
Exceptional Items	-44.16	-34.96	-38.14	-98.37	-54.39
Profit/Loss Before Tax	224.68	369.84	342.45	223.86	397.37
Tax Expenses-Continued Operations
Current Tax	74.43	91.35	87.11	40.17	76.71
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-23.34	-5.17	8.00	-33.46	2.71
Tax For Earlier Years	-1.62	0.00	4.57	0.00	0.00
Total Tax Expenses	49.48	86.18	99.68	6.70	79.41
Profit/Loss After Tax And Before ExtraOrdinary Items	175.21	283.65	242.77	217.16	317.96
Profit/Loss From Continuing Operations	175.21	283.65	242.77	217.16	317.96
Profit/Loss For The Period	175.21	283.65	242.77	217.16	317.96
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	9.69	15.68	13.42	12.01	17.58
Diluted EPS (Rs.)	9.69	15.68	13.42	12.01	17.58
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	45.21	81.38	54.26	27.13	79.12
Tax On Dividend	3.06	15.25	10.23	3.90	12.86
Equity Dividend Rate (%)	25.00	35.00	35.00	15.00	100.00